FDA Warns Stem Cell Supplier Over Unapproved Treatment – Regulatory Focus
|
FDA Warns Stem Cell Supplier Over Unapproved Treatment
Regulatory Focus The US Food and Drug Administration (FDA) on Wednesday warned stem cell product supplier American CryoStem Corporation for marketing an unapproved product after the agency inspected the company's Eatontown, New Jersey site in July. The warning letter … |
